Asset Details
Do you wish to reserve the book?
Current status of photodynamic technology for urothelial cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Current status of photodynamic technology for urothelial cancer
Do you wish to request the book?
Current status of photodynamic technology for urothelial cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Current status of photodynamic technology for urothelial cancer
2022
Overview
5‐Aminolevulinic acid is a new‐generation photosensitizer with high tumor specificity. It has been used successfully in the diagnosis, treatment, and screening of urological cancers including bladder cancer; specifically, it has been used in photodynamic diagnosis to detect tumors by illuminating the lesion with a specific wavelength of light to produce fluorescence in the lesion after administration of 5‐aminolevulinic acid, in photodynamic therapy, which induces tumor cell death via production of cytotoxic reactive oxygen species, and in photodynamic screening, in which porphyrin excretion in the blood and urine is used as a tumor biomarker after administration of 5‐aminolevulinic acid. In addition to these applications in urological cancers, 5‐aminolevulinic acid–based photodynamic technology is expected to be used as a novel strategy for a large number of cancer types because it is based on a property of cancer cells known as the Warburg effect, which is a basic biological property that is common across all cancers. The mechanism of 5‐aminolevulinic acid‐based photodynamic therapy.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc
Subject
/ Aminolevulinic Acid - metabolism
/ Aminolevulinic Acid - therapeutic use
/ Biomarkers, Tumor - metabolism
/ Enzymes
/ Humans
/ Light
/ Peptides
/ Photosensitizing Agents - metabolism
/ Photosensitizing Agents - therapeutic use
/ Reactive Oxygen Species - metabolism
/ Review
/ Tumors
/ Urinary Bladder Neoplasms - diagnosis
/ Urinary Bladder Neoplasms - drug therapy
